JAZZ PHA reported $2.57B in Current Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
ALKERMES ALKS:US USD 1.05B 7.81M
Amarin AMRN:US USD 686.52M 32.6M
Cara Therapeutics CARA:US USD 186.78M 10.61M
Coherus Biosciences CHRS:US USD 448.28M 1.49M
Emergent Biosolutions EBS:US USD 1.12B 34.3M
Endo International Ordinary Shares ENDP:US USD 2.05B 145.74M
Halozyme Therapeutics HALO:US USD 653.2M 111.26M
Heron Therapeutics HRTX:US USD 223.8M 29.6M
Hikma Pharmaceutical HIK:LN USD 2.14B 50M
Horizon Pharma HZNP:US USD 3.41B 208.92M
IONIS PHARMACEUT IONS:US USD 2.15B 39.02M
Lannett LCI:US USD 250.53M 14.13M
Mckesson MCK:US USD 44.66B 1.79B
Nektar Therapeutics NKTR:US USD 599.48M 66.05M
Pacira Pharmaceuticals PCRX:US USD 533.41M 7.2M
Perrigo Ordinary Shares PRGO:US USD 2.58B 68.2M
Revance Therapeutics RVNC:US USD 415.59M 154.65M
Supernus Pharmaceuticals SUPN:US USD 663.89M 38.77M
Teva Pharmaceutical Industries TEVA:US USD 11.45B 711M
Xeris Pharmaceuticals Inc XERS:US USD 148.92M 12.29M
Zoetis ZTS:US USD 6.55B 100M